Premium
Predicting the future relapse of alcohol‐dependent patients from structural and functional brain images
Author(s) -
Seo Sambu,
Mohr Johannes,
Beck Anne,
Wüstenberg Torsten,
Heinz Andreas,
Obermayer Klaus
Publication year - 2015
Publication title -
addiction biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.445
H-Index - 78
eISSN - 1369-1600
pISSN - 1355-6215
DOI - 10.1111/adb.12302
Subject(s) - neuroimaging , orbitofrontal cortex , psychology , ventral striatum , functional neuroimaging , prefrontal cortex , neuroscience , striatum , cognition , dopamine
Abstract In alcohol dependence, individual prediction of treatment outcome based on neuroimaging endophenotypes can help to tailor individual therapeutic offers to patients depending on their relapse risk. We built a prediction model for prospective relapse of alcohol‐dependent patients that combines structural and functional brain images derived from an experiment in which 46 subjects were exposed to alcohol‐related cues. The patient group had been subdivided post hoc regarding relapse behavior defined as a consumption of more than 60 g alcohol for male or more than 40 g alcohol for female patients on one occasion during the 3‐month assessment period (16 abstainers and 30 relapsers). Naïve Bayes, support vector machines and learning vector quantization were used to infer prediction models for relapse based on the mean and maximum values of gray matter volume and brain responses on alcohol‐related cues within a priori defined regions of interest. Model performance was estimated by leave‐one‐out cross‐validation. Learning vector quantization yielded the model with the highest balanced accuracy (79.4 percent, p < 0.0001; 90 percent sensitivity, 68.8 percent specificity). The most informative individual predictors were functional brain activation features in the right and left ventral tegmental areas and the right ventral striatum, as well as gray matter volume features in left orbitofrontal cortex and right medial prefrontal cortex. In contrast, the best pure clinical model reached only chance‐level accuracy (61.3 percent). Our results indicate that an individual prediction of future relapse from imaging measurement outperforms prediction from clinical measurements. The approach may help to target specific interventions at different risk groups.